216 related articles for article (PubMed ID: 24591365)
1. Enhanced antibody responses to an HIV-1 membrane-proximal external region antigen in mice reconstituted with cultured lymphocytes.
Holl TM; Yang G; Kuraoka M; Verkoczy L; Alam SM; Moody MA; Haynes BF; Kelsoe G
J Immunol; 2014 Apr; 192(7):3269-79. PubMed ID: 24591365
[TBL] [Abstract][Full Text] [Related]
2. Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses.
Verkoczy L; Chen Y; Zhang J; Bouton-Verville H; Newman A; Lockwood B; Scearce RM; Montefiori DC; Dennison SM; Xia SM; Hwang KK; Liao HX; Alam SM; Haynes BF
J Immunol; 2013 Sep; 191(5):2538-50. PubMed ID: 23918977
[TBL] [Abstract][Full Text] [Related]
3. Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies.
Yang G; Holl TM; Liu Y; Li Y; Lu X; Nicely NI; Kepler TB; Alam SM; Liao HX; Cain DW; Spicer L; VandeBerg JL; Haynes BF; Kelsoe G
J Exp Med; 2013 Feb; 210(2):241-56. PubMed ID: 23359068
[TBL] [Abstract][Full Text] [Related]
4. N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.
Li D; Liu J; Zhang L; Xu T; Chen J; Wang L; Zhao Q
Virol Sin; 2015 Dec; 30(6):449-56. PubMed ID: 26715302
[TBL] [Abstract][Full Text] [Related]
5. Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant.
Guenaga J; Dosenovic P; Ofek G; Baker D; Schief WR; Kwong PD; Karlsson Hedestam GB; Wyatt RT
PLoS One; 2011 Jan; 6(1):e16074. PubMed ID: 21297864
[TBL] [Abstract][Full Text] [Related]
6. Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10.
Chen Y; Zhang J; Hwang KK; Bouton-Verville H; Xia SM; Newman A; Ouyang YB; Haynes BF; Verkoczy L
J Immunol; 2013 Aug; 191(3):1260-75. PubMed ID: 23825311
[TBL] [Abstract][Full Text] [Related]
7. Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.
Verkoczy L; Chen Y; Bouton-Verville H; Zhang J; Diaz M; Hutchinson J; Ouyang YB; Alam SM; Holl TM; Hwang KK; Kelsoe G; Haynes BF
J Immunol; 2011 Oct; 187(7):3785-97. PubMed ID: 21908739
[TBL] [Abstract][Full Text] [Related]
8. Cross-Reactivity to Kynureninase Tolerizes B Cells That Express the HIV-1 Broadly Neutralizing Antibody 2F5.
Finney J; Yang G; Kuraoka M; Song S; Nojima T; Verkoczy L; Kitamura D; Haynes BF; Kelsoe G
J Immunol; 2019 Dec; 203(12):3268-3281. PubMed ID: 31732530
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
10. Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region.
Verkoczy L; Moody MA; Holl TM; Bouton-Verville H; Scearce RM; Hutchinson J; Alam SM; Kelsoe G; Haynes BF
PLoS One; 2009 Oct; 4(10):e7215. PubMed ID: 19806186
[TBL] [Abstract][Full Text] [Related]
11. Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10.
Doyle-Cooper C; Hudson KE; Cooper AB; Ota T; Skog P; Dawson PE; Zwick MB; Schief WR; Burton DR; Nemazee D
J Immunol; 2013 Sep; 191(6):3186-3191. PubMed ID: 23940276
[TBL] [Abstract][Full Text] [Related]
12. Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.
Zhang J; Alam SM; Bouton-Verville H; Chen Y; Newman A; Stewart S; Jaeger FH; Montefiori DC; Dennison SM; Haynes BF; Verkoczy L
J Immunol; 2014 Feb; 192(4):1693-706. PubMed ID: 24465011
[TBL] [Abstract][Full Text] [Related]
13. Recognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicity.
Huarte N; Araujo A; Arranz R; Lorizate M; Quendler H; Kunert R; Valpuesta JM; Nieva JL
PLoS One; 2012; 7(12):e52740. PubMed ID: 23285173
[TBL] [Abstract][Full Text] [Related]
14. Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies.
Sánchez-Martínez S; Lorizate M; Katinger H; Kunert R; Nieva JL
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):998-1006. PubMed ID: 17067270
[TBL] [Abstract][Full Text] [Related]
15. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.
Tudor D; Yu H; Maupetit J; Drillet AS; Bouceba T; Schwartz-Cornil I; Lopalco L; Tuffery P; Bomsel M
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12680-5. PubMed ID: 22723360
[TBL] [Abstract][Full Text] [Related]
16. Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages.
Zhang R; Verkoczy L; Wiehe K; Munir Alam S; Nicely NI; Santra S; Bradley T; Pemble CW; Zhang J; Gao F; Montefiori DC; Bouton-Verville H; Kelsoe G; Larimore K; Greenberg PD; Parks R; Foulger A; Peel JN; Luo K; Lu X; Trama AM; Vandergrift N; Tomaras GD; Kepler TB; Moody MA; Liao HX; Haynes BF
Sci Transl Med; 2016 Apr; 8(336):336ra62. PubMed ID: 27122615
[TBL] [Abstract][Full Text] [Related]
17. Selection and immune recognition of HIV-1 MPER mimotopes.
Wieczorek L; Peachman K; Steers N; Schoen J; Rao M; Polonis V; Rao V
Virology; 2020 Nov; 550():99-108. PubMed ID: 32980676
[TBL] [Abstract][Full Text] [Related]
18. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes.
Franquelim HG; Chiantia S; Veiga AS; Santos NC; Schwille P; Castanho MA
AIDS; 2011 Feb; 25(4):419-28. PubMed ID: 21245727
[TBL] [Abstract][Full Text] [Related]
20. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
